| 2016 | Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents | 권영주 | Article |
| 2019 | Recent therapeutic trends and promising targets in triple negative breast cancer | 권영주 | Review |
| 2014 | Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors | 권영주 | Article |
| 2014 | Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a] pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor | 권영주 | Article |
| 2011 | Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analogues | 권영주 | Article |
| 2007 | Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors | 이상국; 권영주 | Article |
| 2021 | AK-I-190, a New Catalytic Inhibitor of Topoisomerase II with Anti-Proliferative and Pro-Apoptotic Activity on Androgen-Negative Prostate Cancer Cells | 권영주; 전경화; 황수연 | Article |
| 2018 | Intestinal P-glycoprotein inhibitors, benzoxanthone analogues | 이화정; 권영주; 이재옥 | Article |
| 2018 | Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors | 권영주 | Article |
| 2014 | Reply to the Letter to the Editor "Cobalt-albumin binding (CAB) assay: An advantageous and flaw free testing of albumin-cobalt binding" | 권영주 | Letter |
